Long TSLP transcript expression and release of TSLP induced by TLR ligands and cytokines in human keratinocytes

Journal of Dermatological Science

Volumn 66, Issue 3, 2012, Pages 233-237

  Xie, Yang ^a   Takai, Toshiro ^a   Chen, Xue ^a,b   Okumura, Ko ^a   Ogawa, Hideoki ^a  

^a JUNTENDO UNIVERSITY   (Japan)

^b PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Atopic cytokine milieu; Keratinocyte; Splicing forms; Thymic stromal lymphopoietin; Toll like receptor ligands

Indexed keywords

(2,3 BISPALMITOYLOXYPROPYL)CYSTEINYLGLYCYLASPARTYLPROLYLLYSYLHISTIDYLPROLYLLYSYLSERYLPHENYLALANINE; CALCIPOTRIOL; CALCITRIOL; FLAGELLIN; INTERLEUKIN 13; INTERLEUKIN 4; MESSENGER RNA; POLYINOSINIC POLYCYTIDYLIC ACID; THYMIC STROMAL LYMPHOPOIETIN; TOLL LIKE RECEPTOR AGONIST; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL STIMULATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TSLP GENE;

CALCITRIOL; CELLS, CULTURED; CYTOKINES; DIGLYCERIDES; FLAGELLIN; GENE EXPRESSION; HUMANS; KERATINOCYTES; LIGANDS; OLIGOPEPTIDES; POLY I-C; RECEPTORS, CALCITRIOL; RNA, MESSENGER; TOLL-LIKE RECEPTORS; UP-REGULATION;

EID: 84861342859     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2012.03.007     Document Type: Article

References (30)

1. Takai T. TSLP expression: cellular sources, triggers, and regulatory mechanisms. Allergol Int 2012, 61:3-17.
2. Hanabuchi S., Watanabe N., Liu Y.J. TSLP and immune homeostasis. Allergol Int 2012, 61:19-25.
3. Omori-Miyake M., Ziegler S.F. Mouse models of allergic diseases: TSLP and its functional roles. Allergol Int 2012, 61:27-34.
4. Ito T., Liu Y.J., Arima K. Cellular and molecular mechanisms of TSLP function in human allergic disorders-TSLP programs the " Th2 code" in dendritic cells. Allergol Int 2012, 61:35-43.
5. Liu Y.J. Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 2006, 203:269-273.
6. Soumelis V., Reche P.A., Kanzler H., Yuan W., Edward G., Homey B., et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 2002, 3:673-680.
7. Ebner S., Nguyen V.A., Forstner M., Wang Y.H., Wolfram D., Liu Y.J., et al. Thymic stromal lymphopoietin converts human epidermal Langerhans cells into antigen-presenting cells that induce proallergic T cells. J Allergy Clin Immunol 2007, 119:982-990.
8. Allakhverdi Z., Comeau M.R., Jessup H.K., Yoon B.R., Brewer A., Chartier S., et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or inflammation and potently activates mast cells. J Exp Med 2007, 204:253-258.
9. Rochman I., Watanabe N., Arima K., Liu Y.J., Leonard W.J. Cutting edge: direct action of thymic stromal lymphopoietin on activated human CD4+ T cells. J Immunol 2007, 178:6720-6724.
10. Wong C.K., Hu S., Cheung P.F., Lam C.W. Thymic stromal lymphopoietin induces chemotactic and prosurvival effects in eosinophils: implications in allergic inflammation. Am J Respir Cell Mol Biol 2010, 43:305-315.
11. Wu W.H., Park C.O., Oh S.H., Kim H.J., Kwon Y.S., Bae B.G., et al. Thymic stromal lymphopoietin-activated invariant natural killer T cells trigger an innate allergic immune response in atopic dermatitis. J Allergy Clin Immunol 2010, 126:290-299. e1-4.
12. Holgate S.T. The epithelium takes centre stage in asthma and atopic dermatitis. Trends Immunol 2007, 28:248-251.
13. Ziegler S.F., Artis D. Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol 2010, 11:289-293.
14. Takai T., Ikeda S. Barrier dysfunction caused by environmental proteases in the pathogenesis of allergic diseases. Allergol Int 2011, 60:25-35.
15. Willart M.A., Hammad H. Alarming dendritic cells for allergic sensitization. Allergol Int 2010, 59:95-103.
16. Harada M., Hirota T., Jodo A.I., Doi S., Kameda M., Fujita K., et al. Functional analysis of the thymic stromal lymphopoietin variants in human bronchial epithelial cells. Am J Respir Cell Mol Biol 2009, 40:368-374.
17. Harada M., Hirota T., Jodo A.I., Hitomi Y., Sakashita M., Tsunoda T., et al. Thymic stromal lymphopoietin gene promoter polymorphisms are associated with susceptibility to bronchial asthma. Am J Respir Cell Mol Biol 2011, 44:787-793.
18. Hirota T., Takahashi A., Kubo M., Tsunoda T., Tomita K., Doi S., et al. Genome-wide association study identifies three new susceptibility loci for adult asthma in the Japanese population. Nat Genet 2011, 43:893-896.
19. Kinoshita H., Takai T., Le T.A., Kamijo S., Wang X.L., Ushio H., et al. Cytokine milieu modulates release of thymic stromal lymphopoietin from human keratinocytes stimulated with double-stranded RNA. J Allergy Clin Immunol 2009, 123:179-186.
20. Vu A.T., Chen X., Xie Y., Kamijo S., Ushio H., Kawasaki J., et al. Extracellular double-stranded RNA induces TSLP via an endosomal acidification- and NF-κ B-dependent pathway in human keratinocytes. J Invest Dermatol 2011, 131:2205-2212.
21. Vu A.T., Baba T., Chen X., Le T.A., Kinoshita H., Xie Y., et al. Staphylococcus aureus membrane and diacylated lipopeptide induce thymic stromal lymphopoietin in keratinocytes via the Toll-like receptor 2-Toll-like receptor 6 pathway. J Allergy Clin Immunol 2010, 126:985-993. e1-3.
22. Le T.A., Takai T., Vu A.T., Kinoshita H., Chen X., Ikeda S., et al. Flagellin induces the expression of thymic stromal lymphopoietin in human keratinocytes via toll-like receptor 5. Int Arch Allergy Immunol 2011, 155:31-37.
23. Bogiatzi S.I., Fernandez I., Bichet J.C., Marloie-Provost M.A., Volpe E., Sastre X., et al. Cutting edge: proinflammatory and Th2 cytokines synergize to induce thymic stromal lymphopoietin production by human skin keratinocytes. J Immunol 2007, 178:3373-3377.
24. Li M., Hener P., Zhang Z., Kato S., Metzger D., Chambon P. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci USA 2006, 103:11736-11741.
25. Le T.A., Takai T., Kinoshita H., Suto H., Ikeda S., Okumura K., et al. Inhibition of double-stranded RNA-induced TSLP in human keratinocytes by glucocorticoids. Allergy 2009, 64:1231-1232.
26. Le T.A., Takai T., Vu A.T., Kinoshita H., Ikeda S., Ogawa H., et al. Glucocorticoids inhibit double-stranded RNA-induced thymic stromal lymphopoietin release from keratinocytes in atopic cytokine milieu more effectively than tacrolimus. Int Arch Allergy Immunol 2010, 153:27-34.
27. Fontao L., Laffitte E., Briot A., Kaya G., Roux-Lombard P., Fraitag S., et al. Infliximab infusions for Netherton syndrome: sustained clinical improvement correlates with a reduction of thymic stromal lymphopoietin levels in the skin. J Invest Dermatol 2011, 131:1947-1950.
28. Zheng T., Oh M.H., Oh S.Y., Schroeder J.T., Glick A.B., Zhu Z. Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling. J Invest Dermatol 2009, 129:742-751.
29. Takai T., Vu A.T., Le T.A., Kinoshita H., Ushio H., Ikeda S., et al. Reply. J Allergy Clin Immunol 2009, 124:864-865.
30. Surjit M., Ganti K.P., Mukherji A., Ye T., Hua G., Metzger D., et al. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 2011, 145:224-241.